Status:
COMPLETED
Seroprevalence of Leptospirosis in Val Müstair, Switzerland
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
Cantonal Hospital of St. Gallen
Conditions:
Leptospirosis
Hepatitis E Virus Infection
Eligibility:
All Genders
18+ years
Brief Summary
Human leptospirosis is a zoonotic disease caused by bacteria of the genus Leptospira. Due to its frequent inapparent course or mild severity with unspecific symptoms and limited availability of diagno...
Eligibility Criteria
Inclusion
- Informed consent as documented by signature
- Aged 18 years or older
- Living for at least one year mainly (\>6 months per year) in Val Müstair (including Taufers and Rifair, Italy)
Exclusion
- Inability to give consent
- Inability to follow procedures
- Acute infections/inflammatory disease
Key Trial Info
Start Date :
March 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 15 2024
Estimated Enrollment :
258 Patients enrolled
Trial Details
Trial ID
NCT05300425
Start Date
March 3 2022
End Date
November 15 2024
Last Update
December 13 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel, Division of Internal Medicine
Basel, Switzerland, 4031
2
Center da sanda Val Muestair
Val Müstair, Switzerland, 7536